BioXcel Therapeutics Inc buy BiotechBee
Start price
28.01.23
/
60%
€29.02
Target price
31.12.25
€45.00
Performance (%)
-30.32%
End price
05.05.23
€20.22
Summary
This prediction ended on 05.05.23 with a price of €20.22. The BUY prediction by BiotechBee for BioXcel Therapeutics Inc performed very badly with a performance of -30.32%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BioXcel Therapeutics Inc | - | - | - |
iShares Core DAX® | 1.056% | 1.056% | 18.108% |
iShares Nasdaq 100 | -1.886% | -0.160% | 26.970% |
iShares Nikkei 225® | 2.553% | 4.359% | 17.676% |
iShares S&P 500 | -0.434% | 0.224% | 24.986% |
According to BiotechBee what are the pros and cons of BioXcel Therapeutics Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread BioXcel Therapeutics Inc diskutieren
Buy mit Kursziel 45,0
In the thread Trading BioXcel Therapeutics Inc
Buy beendet
Stopped prediction by BiotechBee for BioXcel Therapeutics Inc
BioXcel Therapeutics Inc
Start price
Target price
Perf. (%)
€2.91
10.12.23
10.12.23
€3.80
30.06.25
30.06.25
12.65%
17.02.24
17.02.24
Could be very worthwhile Investment >20% year